Trends in Pleural Mesothelioma Incidence and Survival in Metropolitan and Nonmetropolitan Areas in the United States
Cancer Medicine · 2025
DOI: 10.1002/cam4.71474 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Alexander J Didier und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, The University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA. Hauptthemen laut MEDLINE: Pleural Neoplasms, Mesothelioma, Malignant, Mesothelioma. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ohio State University.
Abstract (Originalsprache)
Introduction
Pleural mesothelioma (PM) is a rare, aggressive cancer with significant variation in incidence based on geographic factors. Previous studies have highlighted cancer survival disparities between metropolitan and nonmetropolitan populations for other cancers; this data is largely unreported for PM. We aimed to compare incidence trends and cancer‐specific survival (CSS) between metropolitan and nonmetropolitan areas in the United States using the Surveillance, Epidemiology, and End Results (SEER) database.
Methods
We analyzed SEER 18 registries for patients aged ≥ 20 diagnosed with PM between 2004 and 2021. Incidence rates, CSS, and demographic and clinical characteristics were compared between metropolitan and nonmetropolitan areas. Incidence rate ratios (IRRs) were calculated using the Tiwari method. Joinpoint regression was used to assess temporal trends, while Kaplan–Meier and Cox proportional hazard models analyzed survival outcomes.
Results
A total of 8519 PM cases were identified, with 89.3% in metropolitan areas. Nonmetropolitan patients were more likely to be non‐Hispanic Black and had lower chemotherapy ( p = 0.031) and surgery ( p < 0.001) rates. The incidence rate in metropolitan areas declined from 1.4 in 2004 to 0.8 in 2021, while nonmetropolitan areas saw a stable incidence until 2017, followed by a decline to 0.5 in 2021. Metropolitan areas had significantly higher CSS, with 50.3% 1‐year CSS by 2020, compared to 27.7% in nonmetropolitan areas. Multivariate analysis indicated a higher hazard of death in nonmetropolitan areas (HR = 1.18, p < 0.001).
Conclusion
Significant disparities in PM outcomes between metropolitan and nonmetropolitan areas were revealed. Although both regions experienced a decline in incidence over time, survival outcomes remained worse in nonmetropolitan areas. Patients in nonmetropolitan areas were also less likely to receive chemotherapy and surgery, further contributing to the survival gap. These findings highlight the need for targeted interventions to improve treatment access and enhance survival for nonmetropolitan patients with PM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, The University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA.
- Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.
ORCID-Profile: Mingjia Li, Carolyn Presley, Logan Roof
Förderung
- Ohio State University
Zitieren
APA
Didier, A. J., Lennox, C., Li, M., Gheeya, J., Alahmadi, A., Kaufman, J., Memmott, R., He, K., Shields, P., Rolfo, C., Carbone, D. P., Presley, C., Owen, D., & Roof, L. (2025). Trends in Pleural Mesothelioma Incidence and Survival in Metropolitan and Nonmetropolitan Areas in the United States. Cancer Medicine. https://doi.org/10.1002/cam4.71474
Vancouver
Didier AJ, Lennox C, Li M, Gheeya J, Alahmadi A, Kaufman J, et al. Trends in Pleural Mesothelioma Incidence and Survival in Metropolitan and Nonmetropolitan Areas in the United States. Cancer Medicine. 2025. doi:10.1002/cam4.71474
BibTeX
@article{Didier2025,
author = {Didier, Alexander J and Lennox, Charlotte and Li, Mingjia and Gheeya, Jinesh and Alahmadi, Asrar and Kaufman, Jacob and Memmott, Regan and He, Kai and Shields, Peter and Rolfo, Christian and Carbone, David P and Presley, Carolyn and Owen, Dwight and Roof, Logan},
title = {Trends in Pleural Mesothelioma Incidence and Survival in Metropolitan and Nonmetropolitan Areas in the United States},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.71474}
}
EUVIMED